Acthar Gel in African Americans versus Non-African Americans with Symptomatic Sarcoidosis: Physician Assessment of Patient Medical Records

Autor: Bindra J, Chopra I, Hayes K, Niewoehner J, Panaccio MP, Wan GJ

Publikováno v: Therapeutics and Clinical Risk Management, Vol Volume 20, Pp 83-94 (2024)

Jas Bindra,1 Ishveen Chopra,2 Kyle Hayes,3 John Niewoehner,3 Mary Prince Panaccio,3 George J Wan3 1Falcon Research Group, North Potomac, MD, USA; 2Manticore Consultancy, Bethesda, MD, USA; 3Mallinckrodt Pharmaceuticals, Bridgewater, NJ, USACorrespond

Externí odkaz: https://doaj.org/article/cd16966771c84bbaa17fbf19ba8a0e9c

Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection

Autor: Hayes K, Panaccio MP, Houston P, Niewoehner J, Fahim M, Wan GJ, Dhillon B

Publikováno v: Open Access Rheumatology: Research and Reviews, Vol Volume 13, Pp 315-323 (2021)

Kyle Hayes,1 Mary P Panaccio,1 Parul Houston,1 John Niewoehner,1 Mohammed Fahim,2 George J Wan,1 Bhavna Dhillon3 1Mallinckrodt Pharmaceuticals, Hampton, NJ, USA; 2KMK Consulting, Morristown, NJ, USA; 3United Rheumatology, Hauppauge, NY, USACorrespond

Externí odkaz: https://doaj.org/article/6fdd09333fb84fee8d81d9748795ac9c

Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.

Autor: Girman C; CERobs Consulting LLC, Wrightsville Beach, NC, USA., Panaccio MP; Mallinckrodt Pharmaceuticals Inc., Hampton, NJ, USA., Hayes K; Mallinckrodt Pharmaceuticals Inc., Hampton, NJ, USA., Niewoehner J; Mallinckrodt Pharmaceuticals Inc., Hampton, NJ, USA., Wan GJ; Mallinckrodt Pharmaceuticals Inc., Hampton, NJ, USA. George.Wan@mnk.com.

Publikováno v: Advances in therapy [Adv Ther] 2022 Jul; Vol. 39 (7), pp. 3072-3087. Date of Electronic Publication: 2022 May 30.

Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis.

Autor: Fleischmann R; Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, 8144 Walnut Hill Lane, Dallas, TX, 75231, USA. rfleischmann@arthdocs.com., Hayes K; Mallinckrodt Pharmaceuticals, Hampton, NJ, USA., Ahn SW; KMK Consulting Inc, Morristown, NJ, USA., Wan GJ; Mallinckrodt Pharmaceuticals, Hampton, NJ, USA., Panaccio MP; Mallinckrodt Pharmaceuticals, Hampton, NJ, USA., Karlsson D; Mallinckrodt Pharmaceuticals, Hampton, NJ, USA., Furst DE; David Geffen School of Medicine, Division of Rheumatology, University of California Los Angeles, Los Angeles, CA, USA.

Publikováno v: Rheumatology and therapy [Rheumatol Ther] 2022 Apr; Vol. 9 (2), pp. 435-446. Date of Electronic Publication: 2021 Dec 17.

Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis.

Autor: Rice JB; Analysis Group Inc., Boston, MA, USA. Brad.Rice@AnalysisGroup.com., Panaccio MP; Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA., White A; Analysis Group Inc., Boston, MA, USA., Simes M; Analysis Group Inc., Boston, MA, USA., Billmyer E; Analysis Group Inc., Boston, MA, USA., Downes N; Analysis Group Inc., Boston, MA, USA., Niewoehner J; Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA., Wan GJ; Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA.

Publikováno v: Neurology and therapy [Neurol Ther] 2021 Jun; Vol. 10 (1), pp. 149-167. Date of Electronic Publication: 2020 Nov 10.